UTHR logo

United Therapeutics (UTHR) Operating Profit

Annual Operating Profit

$1.18 B
+$205.20 M+20.95%

December 31, 2023

Summary

Performance

1-Year Change

+20.95%

3-Year Change

+99.61%

5-Year Change

+47.12%

15-Year Change

+15.61%

UTHR Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.91%
UTHR annual operating income is higher than 95.91% of companies in Healthcare sector

High & Low

All-time High

$1.18 B
UTHR annual operating income is currently at an all-time high

3-Year Low

$555.90 M
UTHR annual operating income is currently +113.15% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
UTHR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
UTHR next annual earnings announcement has not yet been scheduled

OtherUTHRprofitabilitymetrics:

Annual Operating Margin

50.91%
UTHR annual operating profit margin is 50.91%

Annual Revenue

$2.33 B
UTHR annual revenue is $2.33 billion

Annual Net Income

$984.80 M
UTHR annual net profit is $984.80 million

Annual EPS

$19.81
UTHR annual earnings per share is $19.81

Quarterly Operating Profit

$408.20 M
+$88.30 M+27.60%

September 30, 2024

Summary

Performance

3-Month Change

+27.6%

1-Year Change

+24.83%

3-Year Change

+24.83%

5-Year Change

+144.87%

UTHR Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.72%
UTHR quarterly operating income is higher than 96.72% of companies in Healthcare sector

High & Low

All-time High

$408.20 M
UTHR quarterly operating income is currently at an all-time high

3-Year Low

$169.80 M
UTHR quarterly operating income is currently +140.40% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
UTHR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
UTHR next earnings announcement has not yet been scheduled

OtherUTHRprofitabilitymetrics:

Quarterly Operating Margin

54.51%
UTHR quarterly operating profit margin is 54.51%

Quarterly Revenue

$748.90 M
UTHR quarterly revenue is $748.90 million

Quarterly Net Income

$309.10 M
UTHR quarterly net profit is $309.10 million

Quarterly EPS

$6.39
UTHR quarterly earnings per share is $6.39

TTM Operating Profit

$1.34 B
+$81.20 M+6.43%

September 30, 2024

Summary

Performance

3-Month Change

+6.43%

1-Year Change

+22.18%

3-Year Change

+22.18%

5-Year Change

+111.73%

UTHR TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.94%
UTHR TTM operating income is higher than 95.94% of companies in Healthcare sector

High & Low

All-time High

$1.34 B
UTHR TTM operating income is currently at an all-time high

3-Year Low

$555.90 M
UTHR TTM operating income is currently +141.86% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
UTHR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
UTHR next earnings announcement has not yet been scheduled

OtherUTHRprofitabilitymetrics:

Annual Operating Margin

50.91%
UTHR annual operating profit margin is 50.91%

TTM Revenue

$2.76 B
UTHR TTM revenue is $2.76 billion

TTM Net Income

$1.11 B
UTHR TTM net profit is $1.11 billion

TTM EPS

$22.77
UTHR TTM earnings per share is $22.77

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

$1.18 B
UTHR annual operating income is $1.18 billion

Annual Gross Profit

$2.07 B
UTHR annual gross profit is $2.07 billion

Annual Operating Expenses

$885.10 M
UTHR annual total operating expenses is $885.10 million

UTHR Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.9%+24.8%+22.2%
3 y3 years+99.6%+24.8%+22.2%
5 y5 years+47.1%+144.9%+111.7%

UTHR Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+113.2%at high+140.4%at high+141.9%
5 y5-yearat high+731.6%at high+729.9%at high+816.7%
alltimeall timeat high+731.6%at high+162.2%at high+816.7%

United Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
$408.20 M(+27.6%)
$1.34 B(+6.4%)
Jun 2024
-
$319.90 M(-10.2%)
$1.26 B(+0.5%)
Mar 2024
-
$356.30 M(+37.0%)
$1.26 B(+6.1%)
Dec 2023
$1.18 B(+20.9%)
$260.10 M(-20.5%)
$1.18 B(+7.7%)
Sep 2023
-
$327.00 M(+4.3%)
$1.10 B(+1.2%)
Jun 2023
-
$313.40 M(+10.2%)
$1.09 B(+11.4%)
Mar 2023
-
$284.40 M(+62.0%)
$976.10 M(-0.4%)
Dec 2022
$979.70 M(+76.2%)
$175.60 M(-44.1%)
$979.70 M(+0.6%)
Sep 2022
-
$314.30 M(+55.7%)
$973.90 M(+9.6%)
Jun 2022
-
$201.80 M(-29.9%)
$888.30 M(-2.2%)
Mar 2022
-
$288.00 M(+69.6%)
$908.70 M(+63.5%)
Dec 2021
$555.90 M(-6.4%)
$169.80 M(-25.8%)
$555.90 M(+23.2%)
Sep 2021
-
$228.70 M(+2.9%)
$451.40 M(+1.7%)
Jun 2021
-
$222.20 M(-442.9%)
$443.80 M(+22.6%)
Mar 2021
-
-$64.80 M(-199.2%)
$362.10 M(-39.0%)
Dec 2020
$593.60 M(-416.4%)
$65.30 M(-70.5%)
$593.60 M(+0.3%)
Sep 2020
-
$221.10 M(+57.4%)
$591.80 M(+6.8%)
Jun 2020
-
$140.50 M(-15.7%)
$554.10 M(-12.7%)
Mar 2020
-
$166.70 M(+162.5%)
$635.00 M(-438.5%)
Dec 2019
-$187.60 M(-123.3%)
$63.50 M(-65.4%)
-$187.60 M(+56.9%)
Sep 2019
-
$183.40 M(-17.2%)
-$119.60 M(-22.0%)
Jun 2019
-
$221.40 M(-133.8%)
-$153.40 M(-2.5%)
Mar 2019
-
-$655.90 M(-598.8%)
-$157.40 M(-119.5%)
Dec 2018
$805.40 M(-21.4%)
$131.50 M(-12.1%)
$805.40 M(-0.9%)
Sep 2018
-
$149.60 M(-31.2%)
$812.90 M(-17.6%)
Jun 2018
-
$217.40 M(-29.2%)
$987.10 M(-7.6%)
Mar 2018
-
$306.90 M(+120.8%)
$1.07 B(+4.2%)
Dec 2017
$1.02 B(-3.5%)
$139.00 M(-57.1%)
$1.02 B(-3.3%)
Sep 2017
-
$323.80 M(+8.5%)
$1.06 B(+8.7%)
Jun 2017
-
$298.50 M(+13.2%)
$974.90 M(+1.4%)
Mar 2017
-
$263.60 M(+51.3%)
$961.60 M(-9.4%)
Dec 2016
$1.06 B(+51.9%)
$174.20 M(-27.0%)
$1.06 B(+1.8%)
Sep 2016
-
$238.60 M(-16.3%)
$1.04 B(-12.5%)
Jun 2016
-
$285.20 M(-21.6%)
$1.19 B(+10.5%)
Mar 2016
-
$363.70 M(+134.6%)
$1.08 B(+54.1%)
Dec 2015
$699.00 M(+29.7%)
$155.00 M(-59.9%)
$699.00 M(-3.3%)
Sep 2015
-
$387.00 M(+125.3%)
$722.58 M(+138.2%)
Jun 2015
-
$171.80 M(-1260.8%)
$303.34 M(-1.5%)
Mar 2015
-
-$14.80 M(-108.3%)
$307.86 M(-42.9%)
Dec 2014
$538.80 M(+84.2%)
$178.58 M(-654.0%)
$538.80 M(+62.4%)
Sep 2014
-
-$32.24 M(-118.3%)
$331.73 M(-29.2%)
Jun 2014
-
$176.32 M(-18.4%)
$468.62 M(+13.0%)
Mar 2014
-
$216.14 M(-858.6%)
$414.60 M(+41.7%)
Dec 2013
$292.50 M(-30.6%)
-$28.49 M(-127.2%)
$292.50 M(-34.9%)
Sep 2013
-
$104.65 M(-14.4%)
$449.59 M(+5.6%)
Jun 2013
-
$122.30 M(+30.1%)
$425.66 M(+4.1%)
Mar 2013
-
$94.04 M(-26.9%)
$408.95 M(-3.0%)
Dec 2012
$421.65 M(+32.7%)
$128.60 M(+59.3%)
$421.65 M(+18.3%)
Sep 2012
-
$80.72 M(-23.6%)
$356.55 M(-5.9%)
Jun 2012
-
$105.59 M(-1.1%)
$378.81 M(-2.3%)
Mar 2012
-
$106.74 M(+68.1%)
$387.71 M(+22.0%)
Dec 2011
$317.78 M
$63.51 M(-38.3%)
$317.78 M(+17.9%)
DateAnnualQuarterlyTTM
Sep 2011
-
$102.98 M(-10.1%)
$269.61 M(+17.7%)
Jun 2011
-
$114.49 M(+211.1%)
$229.12 M(+19.9%)
Mar 2011
-
$36.80 M(+140.0%)
$191.11 M(+2.4%)
Dec 2010
$171.31 M(+558.9%)
$15.33 M(-75.5%)
$186.55 M(+10.4%)
Sep 2010
-
$62.49 M(-18.3%)
$169.03 M(+42.9%)
Jun 2010
-
$76.48 M(+137.2%)
$118.28 M(+213.9%)
Mar 2010
-
$32.25 M(-1577.8%)
$37.68 M(+44.9%)
Dec 2009
$26.00 M(-131.7%)
-$2.18 M(-118.6%)
$26.00 M(-124.6%)
Sep 2009
-
$11.74 M(-384.8%)
-$105.68 M(+6.4%)
Jun 2009
-
-$4.12 M(-120.0%)
-$99.35 M(+30.3%)
Mar 2009
-
$20.57 M(-115.4%)
-$76.24 M(-7.1%)
Dec 2008
-$82.06 M(-1401.9%)
-$133.86 M(-841.2%)
-$82.06 M(-289.0%)
Sep 2008
-
$18.06 M(-4.9%)
$43.41 M(+9.9%)
Jun 2008
-
$18.99 M(+28.7%)
$39.51 M(+38.3%)
Mar 2008
-
$14.75 M(-275.7%)
$28.56 M(+353.2%)
Dec 2007
$6.30 M(-78.3%)
-$8.39 M(-159.3%)
$6.30 M(-65.5%)
Sep 2007
-
$14.16 M(+76.0%)
$18.25 M(+17.5%)
Jun 2007
-
$8.04 M(-207.2%)
$15.52 M(-18.3%)
Mar 2007
-
-$7.50 M(-311.5%)
$18.99 M(-34.5%)
Dec 2006
$28.98 M(-32.4%)
$3.55 M(-69.0%)
$28.98 M(-19.0%)
Sep 2006
-
$11.43 M(-0.7%)
$35.79 M(-8.0%)
Jun 2006
-
$11.52 M(+363.6%)
$38.89 M(+0.9%)
Mar 2006
-
$2.48 M(-76.0%)
$38.54 M(-10.2%)
Dec 2005
$42.89 M(+224.7%)
$10.36 M(-28.8%)
$42.89 M(+10.4%)
Sep 2005
-
$14.54 M(+30.2%)
$38.85 M(+29.4%)
Jun 2005
-
$11.16 M(+63.2%)
$30.01 M(+33.9%)
Mar 2005
-
$6.84 M(+8.3%)
$22.42 M(+69.7%)
Dec 2004
$13.21 M(-214.6%)
$6.31 M(+10.8%)
$13.21 M(+291.6%)
Sep 2004
-
$5.70 M(+59.6%)
$3.37 M(-182.9%)
Jun 2004
-
$3.57 M(-250.5%)
-$4.07 M(-61.1%)
Mar 2004
-
-$2.37 M(-32.6%)
-$10.47 M(-9.2%)
Dec 2003
-$11.53 M(-36.0%)
-$3.52 M(+102.1%)
-$11.53 M(+3.7%)
Sep 2003
-
-$1.74 M(-38.4%)
-$11.12 M(-30.1%)
Jun 2003
-
-$2.83 M(-17.6%)
-$15.91 M(+10.0%)
Mar 2003
-
-$3.43 M(+10.2%)
-$14.46 M(-19.7%)
Dec 2002
-$18.00 M(-61.6%)
-$3.11 M(-52.4%)
-$18.00 M(-26.2%)
Sep 2002
-
-$6.54 M(+374.0%)
-$24.40 M(-18.0%)
Jun 2002
-
-$1.38 M(-80.2%)
-$29.76 M(-28.0%)
Mar 2002
-
-$6.97 M(-26.7%)
-$41.36 M(-10.6%)
Dec 2001
-$46.94 M(-42.4%)
-$9.51 M(-20.0%)
-$46.28 M(-31.8%)
Sep 2001
-
-$11.90 M(-8.3%)
-$67.83 M(+2.2%)
Jun 2001
-
-$12.97 M(+9.1%)
-$66.36 M(-20.9%)
Mar 2001
-
-$11.89 M(-61.7%)
-$83.91 M(+3.0%)
Dec 2000
-$81.50 M(+130.5%)
-$31.07 M(+198.1%)
-$81.50 M(+36.1%)
Sep 2000
-
-$10.42 M(-65.8%)
-$59.89 M(+5.9%)
Jun 2000
-
-$30.52 M(+221.6%)
-$56.57 M(+75.4%)
Mar 2000
-
-$9.49 M(+0.3%)
-$32.25 M(-8.0%)
Dec 1999
-$35.36 M(+165.0%)
-$9.46 M(+33.3%)
-$35.06 M(+37.0%)
Sep 1999
-
-$7.10 M(+14.5%)
-$25.60 M(+38.4%)
Jun 1999
-
-$6.20 M(-49.6%)
-$18.50 M(+50.4%)
Mar 1999
-
-$12.30 M
-$12.30 M
Dec 1998
-$13.35 M
-
-

FAQ

  • What is United Therapeutics annual operating income?
  • What is the all time high annual operating profit for United Therapeutics?
  • What is United Therapeutics annual operating profit year-on-year change?
  • What is United Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for United Therapeutics?
  • What is United Therapeutics quarterly operating profit year-on-year change?
  • What is United Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for United Therapeutics?
  • What is United Therapeutics TTM operating profit year-on-year change?

What is United Therapeutics annual operating income?

The current annual operating profit of UTHR is $1.18 B

What is the all time high annual operating profit for United Therapeutics?

United Therapeutics all-time high annual operating income is $1.18 B

What is United Therapeutics annual operating profit year-on-year change?

Over the past year, UTHR annual operating income has changed by +$205.20 M (+20.95%)

What is United Therapeutics quarterly operating income?

The current quarterly operating profit of UTHR is $408.20 M

What is the all time high quarterly operating profit for United Therapeutics?

United Therapeutics all-time high quarterly operating income is $408.20 M

What is United Therapeutics quarterly operating profit year-on-year change?

Over the past year, UTHR quarterly operating income has changed by +$81.20 M (+24.83%)

What is United Therapeutics TTM operating income?

The current TTM operating profit of UTHR is $1.34 B

What is the all time high TTM operating profit for United Therapeutics?

United Therapeutics all-time high TTM operating income is $1.34 B

What is United Therapeutics TTM operating profit year-on-year change?

Over the past year, UTHR TTM operating income has changed by +$244.10 M (+22.18%)